The cost of cancer treatment in Portugal
- PMID: 28955401
- PMCID: PMC5606294
- DOI: 10.3332/ecancer.2017.765
The cost of cancer treatment in Portugal
Abstract
Introduction: Cancer is the second most common cause of death in Portugal, with 24.3% of these deaths caused by malignant neoplasms. The strong impact on lost productivity and rising treatment costs make cancer a priority. In order to understand, compare, and control costs by promoting transparency in the health system, it is vital to analyse the cost of oncological diseases. This study aims to estimate the economic burden associated with the treatment of cancer in Portugal by calculating the direct medical costs.
Materials and methods: A prevalence-based study was conducted. The approaches used to estimate the costs were the top-down and gross costing techniques. In order to identify, quantify, and value all of the costs associated with the treatment of cancer, several sources of data were consulted to obtain the most up-to-date information on hospital care and a modified Delphi Panel was created to obtain data on primary health care.
Results: The annual cost of cancer treatment in Portugal amounted to 867 million euros, representing 5.5% of the total expenditure for health and 84 euros per capita. The main component of this cost is antineoplastic drugs, which account for 31.5% of the total.
Discussion and conclusion: By comparing the costs calculated in this study with those of the single Portuguese study conducted in 2009 and the European study carried out in 2013, we found that the annual cost for cancer treatment increased by about 300 million euros. An increase in incidence and the rising cost of drugs can explain this difference.
Keywords: cancer; costs; economics; health; health technology assessment.
Figures
Similar articles
-
[Cost of cancer care in Portugal].Acta Med Port. 2009 Sep-Oct;22(5):525-36. Epub 2009 Oct 22. Acta Med Port. 2009. PMID: 19944035 Portuguese.
-
Atherosclerosis: The cost of illness in Portugal.Rev Port Cardiol (Engl Ed). 2021 Jun;40(6):409-419. doi: 10.1016/j.repce.2020.08.003. Epub 2021 Feb 6. Rev Port Cardiol (Engl Ed). 2021. PMID: 34274081
-
Haemophilia A: health and economic burden of a rare disease in Portugal.Orphanet J Rare Dis. 2019 Sep 4;14(1):211. doi: 10.1186/s13023-019-1175-5. Orphanet J Rare Dis. 2019. PMID: 31484564 Free PMC article.
-
The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.Tob Use Insights. 2015 Jul 14;8:1-35. doi: 10.4137/TUI.S15628. eCollection 2015. Tob Use Insights. 2015. PMID: 26242225 Free PMC article. Review.
-
[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].Encephale. 2005 Mar-Apr;31(2):235-46. doi: 10.1016/s0013-7006(05)82390-5. Encephale. 2005. PMID: 15959450 Review. French.
Cited by
-
Assessment of Cancer Care Costs in Disease-Specific Cancer Care Pathways.Int J Environ Res Public Health. 2020 Jul 2;17(13):4765. doi: 10.3390/ijerph17134765. Int J Environ Res Public Health. 2020. PMID: 32630745 Free PMC article.
-
COVID-19: What Is Next for Portugal?Front Public Health. 2020 Aug 21;8:392. doi: 10.3389/fpubh.2020.00392. eCollection 2020. Front Public Health. 2020. PMID: 32974253 Free PMC article.
-
Real-world treatment patterns and survival outcomes for advanced non-small cell lung cancer in the pre-immunotherapy era in Portugal: a retrospective analysis from the I-O Optimise initiative.BMC Pulm Med. 2020 Sep 10;20(1):240. doi: 10.1186/s12890-020-01270-z. BMC Pulm Med. 2020. PMID: 32912174 Free PMC article.
-
Cancer cost profiles: The Epicost estimation approach.Front Public Health. 2022 Sep 21;10:974505. doi: 10.3389/fpubh.2022.974505. eCollection 2022. Front Public Health. 2022. PMID: 36211660 Free PMC article.
-
Burden of Disease and Cost of Illness of Triple-Negative Breast Cancer in Portugal.Pharmacoecon Open. 2025 May;9(3):423-431. doi: 10.1007/s41669-024-00552-0. Epub 2025 Feb 11. Pharmacoecon Open. 2025. PMID: 39932637 Free PMC article.
References
-
- European Cancer Observatory, International Agency for Research on Cancer. Estimated Cancer Incidence, Mortality and Prevalence, 2012, Portugal. [January 17]. Available at: Http://eco.iarc.fr/EUCAN/Country.aspx?ISOCountryCd=620.
-
- National Statistics Institute Statistical Yearbook of Portugal. Lisbon: INE; 2014. 2014.
-
- ORGANIZATION FOR ECONOMIC CO-OPERATION AND DEVELOPMENT - OECD. OECD.Stat. [December 16]. Available at: Http://stats.oecd.org/viewhtml.aspx?datasetcode=HEALTH_STAT&lang=en.
-
- Institute for Health Metrics and Evaluation. Portugal: 2015. [March 17]. Global Burden of disease. Available at: Http://ghdx.healthdata.org/gbd-results-tool.
-
- Think Tank. 2nd. Lisbon: National School of Public Health; 2014. Inovar Saúde (Innovate Health) Pensar a Saúde: acesso do cidadão à inovação terapêutica – Oncologia (Think Health: citizen’s access to therapeutic innovation - Oncology)
LinkOut - more resources
Full Text Sources
Other Literature Sources